The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2020
Filed:
May. 21, 2019
Applicant:
Croma-pharma Gesellschaft M.b.h., Leobendorf, AT;
Inventor:
Martin Prinz, Leobendorf, AT;
Assignee:
CROMA-PHARMA GESELLCHAFT M.B.H., Leobendorf, AT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/61 (2017.01); A61K 51/06 (2006.01); A61K 47/18 (2017.01); A61K 9/08 (2006.01); A61K 31/715 (2006.01); B65D 65/40 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); B65D 81/26 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/715 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61K 47/61 (2017.08); A61K 51/06 (2013.01); B65D 65/40 (2013.01); B65D 81/266 (2013.01);
Abstract
A method of preventing or treating an eye condition includes administering a sterile aqueous ophthalmic solution to an eye for the prevention or treatment of dry eye syndrome or dry eye sign and/or dry eye symptom. The sterile aqueous ophthalmic solution includes about 0.05% to about 0.5% (w/w) of N—(N-acetylcysteinyl-)chitosan or a pharmaceutically acceptable salt thereof in a carrier solution, wherein the N—(N-acetylcysteinyl-)chitosan has a content of free thiol groups in an amount of from 80 μmol/g polymer to 280 μmol/g polymer.